-
1
-
-
0017326573
-
Some pharmacological investigations of embelin and its semisynthetic derivatives
-
Gupta OP, Ali MM, Ray Ghatak BJ, Atal CK,. Some pharmacological investigations of embelin and its semisynthetic derivatives. Indian J Physiol Pharmacol 1977; 21: 31-39.
-
(1977)
Indian J Physiol Pharmacol
, vol.21
, pp. 31-39
-
-
Gupta, O.P.1
Ali, M.M.2
Ray Ghatak, B.J.3
Atal, C.K.4
-
2
-
-
0028985240
-
[3H]-thymidine uptake and lipid peroxidation by tumor cells on embelin treatment: An in vitro study
-
Chitra M, Sukumar E, Devi CS,. [3H]-thymidine uptake and lipid peroxidation by tumor cells on embelin treatment: An in vitro study. Oncology 1995; 52: 66-68.
-
(1995)
Oncology
, vol.52
, pp. 66-68
-
-
Chitra, M.1
Sukumar, E.2
Devi, C.S.3
-
3
-
-
2342448582
-
Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database
-
Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, Lippman ME, Yang D, Wang S,. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem 2004; 47: 2430-2440.
-
(2004)
J Med Chem
, vol.47
, pp. 2430-2440
-
-
Nikolovska-Coleska, Z.1
Xu, L.2
Hu, Z.3
Tomita, Y.4
Li, P.5
Roller, P.P.6
Wang, R.7
Fang, X.8
Guo, R.9
Zhang, M.10
Lippman, M.E.11
Yang, D.12
Wang, S.13
-
4
-
-
33845883544
-
Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products
-
Ahn KS, Sethi G, Aggarwal BB,. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Mol Pharmacol 2007; 71: 209-219.
-
(2007)
Mol Pharmacol
, vol.71
, pp. 209-219
-
-
Ahn, K.S.1
Sethi, G.2
Aggarwal, B.B.3
-
5
-
-
55949092012
-
Cell-penetrating peptide-conjugated XIAP-inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation
-
Sasaki Y, Minamizawa M, Ambo A, Sugawara S, Ogawa Y, Nitta K,. Cell-penetrating peptide-conjugated XIAP-inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation. Febs J 2008; 275: 6011-6021.
-
(2008)
Febs J
, vol.275
, pp. 6011-6021
-
-
Sasaki, Y.1
Minamizawa, M.2
Ambo, A.3
Sugawara, S.4
Ogawa, Y.5
Nitta, K.6
-
6
-
-
34548662911
-
Effect of the XIAP inhibitor embelin on TRAIL-induced apoptosis of pancreatic cancer cells
-
Mori T, Doi R, Kida A, Nagai K, Kami K, Ito D, Toyoda E, Kawaguchi Y, Uemoto S,. Effect of the XIAP inhibitor embelin on TRAIL-induced apoptosis of pancreatic cancer cells. J Surg Res 2007; 142: 281-286.
-
(2007)
J Surg Res
, vol.142
, pp. 281-286
-
-
Mori, T.1
Doi, R.2
Kida, A.3
Nagai, K.4
Kami, K.5
Ito, D.6
Toyoda, E.7
Kawaguchi, Y.8
Uemoto, S.9
-
7
-
-
33645640921
-
Cell death in pancreatitis: Caspases protect from necrotizing pancreatitis
-
Mareninova OA, Sung KF, Hong P, Lugea A, Pandol SJ, Gukovsky I, Gukovskaya AS,. Cell death in pancreatitis: Caspases protect from necrotizing pancreatitis. J Biol Chem 2006; 281: 3370-3381.
-
(2006)
J Biol Chem
, vol.281
, pp. 3370-3381
-
-
Mareninova, O.A.1
Sung, K.F.2
Hong, P.3
Lugea, A.4
Pandol, S.J.5
Gukovsky, I.6
Gukovskaya, A.S.7
-
8
-
-
38349155799
-
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression
-
Aird KM, Ding X, Baras A, Wei J, Morse MA, Clay T, Lyerly HK, Devi GR,. Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression. Mol Cancer Ther 2008; 7: 38-47.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 38-47
-
-
Aird, K.M.1
Ding, X.2
Baras, A.3
Wei, J.4
Morse, M.A.5
Clay, T.6
Lyerly, H.K.7
Devi, G.R.8
-
9
-
-
66349089835
-
Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of embelin on colon carcinogenesis
-
Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma J, Zou B, Gu Q, Wang J, Pang R, Lan HY, Wong BC,. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of embelin on colon carcinogenesis. Cancer Res 2009; 69: 4776-4783.
-
(2009)
Cancer Res
, vol.69
, pp. 4776-4783
-
-
Dai, Y.1
Qiao, L.2
Chan, K.W.3
Yang, M.4
Ye, J.5
Ma, J.6
Zou, B.7
Gu, Q.8
Wang, J.9
Pang, R.10
Lan, H.Y.11
Wong, B.C.12
-
10
-
-
79958095970
-
Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN
-
Heo JY, Kim HJ, Kim SM, Park KR, Park SY, Kim SW, Nam D, Jang HJ, Lee SG, Ahn KS, Kim SH, Shim BS, Choi SH,. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN. Cancer Lett 2011; 308: 71-80.
-
(2011)
Cancer Lett
, vol.308
, pp. 71-80
-
-
Heo, J.Y.1
Kim, H.J.2
Kim, S.M.3
Park, K.R.4
Park, S.Y.5
Kim, S.W.6
Nam, D.7
Jang, H.J.8
Lee, S.G.9
Ahn, K.S.10
Kim, S.H.11
Shim, B.S.12
Choi, S.H.13
-
11
-
-
84856017848
-
Natural IAP inhibitor embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer
-
Dai Y, Desano J, Qu Y, Tang W, Meng Y, Lawrence TS, Xu L,. Natural IAP inhibitor embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer. Am J Cancer Res 2011; 1: 128-143.
-
(2011)
Am J Cancer Res
, vol.1
, pp. 128-143
-
-
Dai, Y.1
Desano, J.2
Qu, Y.3
Tang, W.4
Meng, Y.5
Lawrence, T.S.6
Xu, L.7
-
12
-
-
27844580749
-
Embelin derivatives and their anticancer activity through microtubule disassembly
-
Xu M, Cui J, Fu H, Proksch P, Lin W, Li M,. Embelin derivatives and their anticancer activity through microtubule disassembly. Planta Med 2005; 71: 944-948.
-
(2005)
Planta Med
, vol.71
, pp. 944-948
-
-
Xu, M.1
Cui, J.2
Fu, H.3
Proksch, P.4
Lin, W.5
Li, M.6
-
13
-
-
0141927222
-
Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer
-
Gao N, Zhang Z, Jiang BH, Shi X,. Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem Biophys Res Commun 2003; 310: 1124-1132.
-
(2003)
Biochem Biophys Res Commun
, vol.310
, pp. 1124-1132
-
-
Gao, N.1
Zhang, Z.2
Jiang, B.H.3
Shi, X.4
-
14
-
-
24944480788
-
The Akt-mTOR tango and its relevance to cancer
-
Hay N,. The Akt-mTOR tango and its relevance to cancer. Cancer Cell 2005; 8: 179-183.
-
(2005)
Cancer Cell
, vol.8
, pp. 179-183
-
-
Hay, N.1
-
15
-
-
78649692667
-
Biomarkers and patient selection for PI3K/Akt/mTOR targeted therapies: Current status and future directions
-
Bartlett JM,. Biomarkers and patient selection for PI3K/Akt/mTOR targeted therapies: Current status and future directions. Clin Breast Cancer 2010; 10 (Suppl. 3): S86-S95.
-
(2010)
Clin Breast Cancer
, vol.10
, Issue.SUPPL.. 3
-
-
Bartlett, J.M.1
-
16
-
-
78649706942
-
Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis
-
McAuliffe PF, Meric-Bernstam F, Mills GB, Gonzalez-Angulo AM,. Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis. Clin Breast Cancer 2010; 10 (Suppl. 3): S59-S65.
-
(2010)
Clin Breast Cancer
, vol.10
, Issue.SUPPL.. 3
-
-
McAuliffe, P.F.1
Meric-Bernstam, F.2
Mills, G.B.3
Gonzalez-Angulo, A.M.4
-
17
-
-
0030702123
-
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
-
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME,. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-241.
-
(1997)
Cell
, vol.91
, pp. 231-241
-
-
Datta, S.R.1
Dudek, H.2
Tao, X.3
Masters, S.4
Fu, H.5
Gotoh, Y.6
Greenberg, M.E.7
-
18
-
-
0033582929
-
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
-
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME,. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-868.
-
(1999)
Cell
, vol.96
, pp. 857-868
-
-
Brunet, A.1
Bonni, A.2
Zigmond, M.J.3
Lin, M.Z.4
Juo, P.5
Hu, L.S.6
Anderson, M.J.7
Arden, K.C.8
Blenis, J.9
Greenberg, M.E.10
-
19
-
-
0034698170
-
Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1
-
Collado M, Medema RH, Garcia-Cao I, Dubuisson ML, Barradas M, Glassford J, Rivas C, Burgering BM, Serrano M, Lam EW,. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J Biol Chem 2000; 275: 21960-21968.
-
(2000)
J Biol Chem
, vol.275
, pp. 21960-21968
-
-
Collado, M.1
Medema, R.H.2
Garcia-Cao, I.3
Dubuisson, M.L.4
Barradas, M.5
Glassford, J.6
Rivas, C.7
Burgering, B.M.8
Serrano, M.9
Lam, E.W.10
-
20
-
-
43049131769
-
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
-
LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA,. Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations. Drug Resist Updat 2008; 11: 32-50.
-
(2008)
Drug Resist Updat
, vol.11
, pp. 32-50
-
-
Lopiccolo, J.1
Blumenthal, G.M.2
Bernstein, W.B.3
Dennis, P.A.4
-
21
-
-
4043171462
-
Upstream and downstream of mTOR
-
Hay N, Sonenberg N,. Upstream and downstream of mTOR. Genes Dev 2004; 18: 1926-1945.
-
(2004)
Genes Dev
, vol.18
, pp. 1926-1945
-
-
Hay, N.1
Sonenberg, N.2
-
22
-
-
1042267229
-
Determinants of rapamycin sensitivity in breast cancer cells
-
Noh WC, Mondesire WH, Peng J, Jian W, Zhang H, Dong J, Mills GB, Hung MC, Meric-Bernstam F,. Determinants of rapamycin sensitivity in breast cancer cells. Clin Cancer Res 2004; 10: 1013-1023.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 1013-1023
-
-
Noh, W.C.1
Mondesire, W.H.2
Peng, J.3
Jian, W.4
Zhang, H.5
Dong, J.6
Mills, G.B.7
Hung, M.C.8
Meric-Bernstam, F.9
-
23
-
-
33751162384
-
Therapeutic targets: MTOR and related pathways
-
Dancey JE,. Therapeutic targets: MTOR and related pathways. Cancer Biol Ther 2006; 5: 1065-1073.
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 1065-1073
-
-
Dancey, J.E.1
-
24
-
-
0034596364
-
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
-
Barlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Sauter G, Kallioniemi OP, Kallioniemi A,. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst 2000; 92: 1252-1259.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 1252-1259
-
-
Barlund, M.1
Forozan, F.2
Kononen, J.3
Bubendorf, L.4
Chen, Y.5
Bittner, M.L.6
Torhorst, J.7
Haas, P.8
Bucher, C.9
Sauter, G.10
Kallioniemi, O.P.11
Kallioniemi, A.12
-
25
-
-
2442534048
-
Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients
-
van der Hage JA, van den Broek LJ, Legrand C, Clahsen PC, Bosch CJ, Robanus-Maandag EC, van de Velde CJ, van de Vijver MJ,. Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients. Br J Cancer 2004; 90: 1543-1550.
-
(2004)
Br J Cancer
, vol.90
, pp. 1543-1550
-
-
Van Der Hage, J.A.1
Van Den Broek, L.J.2
Legrand, C.3
Clahsen, P.C.4
Bosch, C.J.5
Robanus-Maandag, E.C.6
Van De Velde, C.J.7
Van De Vijver, M.J.8
-
26
-
-
80053950522
-
Beta-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation
-
Park KR, Nam D, Yun HM, Lee SG, Jang HJ, Sethi G, Cho SK, Ahn KS,. beta-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett 2011; 312: 178-188.
-
(2011)
Cancer Lett
, vol.312
, pp. 178-188
-
-
Park, K.R.1
Nam, D.2
Yun, H.M.3
Lee, S.G.4
Jang, H.J.5
Sethi, G.6
Cho, S.K.7
Ahn, K.S.8
-
27
-
-
33747880070
-
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins
-
Xu Y, Chen SY, Ross KN, Balk SP,. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res 2006; 66: 7783-7792.
-
(2006)
Cancer Res
, vol.66
, pp. 7783-7792
-
-
Xu, Y.1
Chen, S.Y.2
Ross, K.N.3
Balk, S.P.4
-
28
-
-
0032894222
-
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines
-
Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H,. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Cancer Res 1999; 59: 227-233.
-
(1999)
Cancer Res
, vol.59
, pp. 227-233
-
-
Putz, T.1
Culig, Z.2
Eder, I.E.3
Nessler-Menardi, C.4
Bartsch, G.5
Grunicke, H.6
Uberall, F.7
Klocker, H.8
-
29
-
-
4344591508
-
Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells
-
Uzgare AR, Isaacs JT,. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells. Cancer Res 2004; 64: 6190-6199.
-
(2004)
Cancer Res
, vol.64
, pp. 6190-6199
-
-
Uzgare, A.R.1
Isaacs, J.T.2
-
30
-
-
0033575051
-
Cancer surveillance series: Interpreting trends in prostate cancer-part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
-
Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS,. Cancer surveillance series: Interpreting trends in prostate cancer-part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999; 91: 1017-1024.
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1017-1024
-
-
Hankey, B.F.1
Feuer, E.J.2
Clegg, L.X.3
Hayes, R.B.4
Legler, J.M.5
Prorok, P.C.6
Ries, L.A.7
Merrill, R.M.8
Kaplan, R.S.9
-
31
-
-
0017720307
-
Latent carcinoma of prostate at autopsy in seven areas: The International Agency for Research on Cancer, Lyons, France
-
Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H,. Latent carcinoma of prostate at autopsy in seven areas: The International Agency for Research on Cancer, Lyons, France. Int J Cancer 1977; 20: 680-688.
-
(1977)
Int J Cancer
, vol.20
, pp. 680-688
-
-
Breslow, N.1
Chan, C.W.2
Dhom, G.3
Drury, R.A.4
Franks, L.M.5
Gellei, B.6
Lee, Y.S.7
Lundberg, S.8
Sparke, B.9
Sternby, N.H.10
Tulinius, H.11
-
32
-
-
80054025905
-
Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India
-
Ganesh B, Saoba SL, Sarade MN, Pinjari SV,. Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India. Indian J Urol 2011; 27: 345-350.
-
(2011)
Indian J Urol
, vol.27
, pp. 345-350
-
-
Ganesh, B.1
Saoba, S.L.2
Sarade, M.N.3
Pinjari, S.V.4
-
33
-
-
0037734017
-
Position of the American Dietetic Association and Dietitians of Canada: Vegetarian diets
-
Canada. ADADo
-
Canada. ADADo. Position of the American Dietetic Association and Dietitians of Canada: Vegetarian diets. J Am Diet Assoc 2003; 103: 748-765.
-
(2003)
J Am Diet Assoc
, vol.103
, pp. 748-765
-
-
-
35
-
-
68149132860
-
Micellar delivery of bicalutamide and embelin for treating prostate cancer
-
Danquah M, Li F, Duke CB III, Miller DD, Mahato RI,. Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharm Res 2009; 26: 2081-2092.
-
(2009)
Pharm Res
, vol.26
, pp. 2081-2092
-
-
Danquah, M.1
Li, F.2
Duke Iii, C.B.3
Miller, D.D.4
Mahato, R.I.5
-
36
-
-
77957961226
-
Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling
-
Hussain AR, Uddin S, Ahmed M, Bu R, Ahmed SO, Abubaker J, Sultana M, Ajarim D, Al-Dayel F, Bavi PP, Al-Kuraya KS,. Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling. J Pathol 2010; 222: 180-190.
-
(2010)
J Pathol
, vol.222
, pp. 180-190
-
-
Hussain, A.R.1
Uddin, S.2
Ahmed, M.3
Bu, R.4
Ahmed, S.O.5
Abubaker, J.6
Sultana, M.7
Ajarim, D.8
Al-Dayel, F.9
Bavi, P.P.10
Al-Kuraya, K.S.11
-
37
-
-
0034749615
-
Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state
-
Murillo H, Huang H, Schmidt LJ, Smith DI, Tindall DJ,. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology 2001; 142: 4795-4805.
-
(2001)
Endocrinology
, vol.142
, pp. 4795-4805
-
-
Murillo, H.1
Huang, H.2
Schmidt, L.J.3
Smith, D.I.4
Tindall, D.J.5
-
38
-
-
0035379555
-
Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38
-
Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr., Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 2001; 276: 18934-18940.
-
(2001)
J Biol Chem
, vol.276
, pp. 18934-18940
-
-
Madrid, L.V.1
Mayo, M.W.2
Reuther, J.Y.3
Baldwin, Jr.A.S.4
-
39
-
-
36749091741
-
Nuclear factor-kappa B: From clone to clinic
-
Ahn KS, Sethi G, Aggarwal BB,. Nuclear factor-kappa B: From clone to clinic. Curr Mol Med 2007; 7: 619-637.
-
(2007)
Curr Mol Med
, vol.7
, pp. 619-637
-
-
Ahn, K.S.1
Sethi, G.2
Aggarwal, B.B.3
-
40
-
-
61449163822
-
The role of mTOR in the management of solid tumors: An overview
-
Strimpakos AS, Karapanagiotou EM, Saif MW, Syrigos KN,. The role of mTOR in the management of solid tumors: An overview. Cancer Treat Rev 2009; 35: 148-159.
-
(2009)
Cancer Treat Rev
, vol.35
, pp. 148-159
-
-
Strimpakos, A.S.1
Karapanagiotou, E.M.2
Saif, M.W.3
Syrigos, K.N.4
-
41
-
-
11244297916
-
Dysregulation of the TSC-mTOR pathway in human disease
-
Inoki K, Corradetti MN, Guan KL,. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005; 37: 19-24.
-
(2005)
Nat Genet
, vol.37
, pp. 19-24
-
-
Inoki, K.1
Corradetti, M.N.2
Guan, K.L.3
-
42
-
-
37449024702
-
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
-
DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB,. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7: 11-20.
-
(2008)
Cell Metab
, vol.7
, pp. 11-20
-
-
Deberardinis, R.J.1
Lum, J.J.2
Hatzivassiliou, G.3
Thompson, C.B.4
-
43
-
-
58749107489
-
Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours
-
Campone M, Levy V, Bourbouloux E, Berton Rigaud D, Bootle D, Dutreix C, Zoellner U, Shand N, Calvo F, Raymond E,. Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours. Br J Cancer 2009; 100: 315-321.
-
(2009)
Br J Cancer
, vol.100
, pp. 315-321
-
-
Campone, M.1
Levy, V.2
Bourbouloux, E.3
Berton Rigaud, D.4
Bootle, D.5
Dutreix, C.6
Zoellner, U.7
Shand, N.8
Calvo, F.9
Raymond, E.10
-
44
-
-
1642586272
-
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
-
Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW,. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004; 428: 332-337.
-
(2004)
Nature
, vol.428
, pp. 332-337
-
-
Wendel, H.G.1
De Stanchina, E.2
Fridman, J.S.3
Malina, A.4
Ray, S.5
Kogan, S.6
Cordon-Cardo, C.7
Pelletier, J.8
Lowe, S.W.9
-
45
-
-
0035949699
-
AKT plays a central role in tumorigenesis
-
Testa JR, Bellacosa A,. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 2001; 98: 10983-10985.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 10983-10985
-
-
Testa, J.R.1
Bellacosa, A.2
-
46
-
-
0345732497
-
Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24
-
Lebedeva IV, Sarkar D, Su ZZ, Kitada S, Dent P, Stein CA, Reed JC, Fisher PB,. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene 2003; 22: 8758-8773.
-
(2003)
Oncogene
, vol.22
, pp. 8758-8773
-
-
Lebedeva, I.V.1
Sarkar, D.2
Su, Z.Z.3
Kitada, S.4
Dent, P.5
Stein, C.A.6
Reed, J.C.7
Fisher, P.B.8
-
47
-
-
17844367156
-
Survivin mediates resistance to antiandrogen therapy in prostate cancer
-
Zhang M, Latham DE, Delaney MA, Chakravarti A,. Survivin mediates resistance to antiandrogen therapy in prostate cancer. Oncogene 2005; 24: 2474-2482.
-
(2005)
Oncogene
, vol.24
, pp. 2474-2482
-
-
Zhang, M.1
Latham, D.E.2
Delaney, M.A.3
Chakravarti, A.4
-
48
-
-
0030740005
-
The modular phosphorylation and activation of p70s6k
-
Pullen N, Thomas G,. The modular phosphorylation and activation of p70s6k. FEBS Lett 1997; 410: 78-82.
-
(1997)
FEBS Lett
, vol.410
, pp. 78-82
-
-
Pullen, N.1
Thomas, G.2
-
49
-
-
27544446579
-
Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)
-
Mencher SK, Wang LG,. Promiscuous drugs compared to selective drugs (promiscuity can be a virtue). BMC Clin Pharmacol 2005; 5: 3.
-
(2005)
BMC Clin Pharmacol
, vol.5
, pp. 3
-
-
Mencher, S.K.1
Wang, L.G.2
|